Enterprise of Rosatom State Corporation
Back to website

Industry news


Ru-82 3D PET/CT MPI training leads to 94% inter-reader agreement

The Rubidium-ARMI (alternative radiopharmaceutical for myocardial imaging) multicenter trial has established a bar for assessing myocardial perfusion imaging (MPI). A team of researchers standardized imaging and interpretation protocols associated with the Rubidium-ARMI trial and then assessed them against previous studies. Results showed that standardized interpretation and optimized imaging protocols lead to 94 percent inter-reader agreement, which meets or exceeds that of previous SPECT studies that showed a range of agreement from 68 to 97 percent agreement.

For more information visit: www.molecularimaging.net


comments powered by Disqus